Description

The Aspirin-Guide app from researchers at Brigham and Women’s Hospital, Harvard Medical School, helps clinicians decide which patients are candidates for the use of low-dose aspirin (75 to 100 mg/d) in the primary prevention of atherosclerotic cardiovascular disease (ASCVD) by balancing the ASCVD benefits against the risk of harm due to gastrointestinal (GI) or other bleeding.

The app has several unique features, including:

*calculates a 10-year cardiovascular disease risk score (heart disease and stroke for the patient
*the ability to email a summary of the decision-making process to the patient

Aspirin-Guide incorporates information about the patient’s risk factors to calculate a 10-yr ASCVD risk score (the ACC/AHA ASCVD score) and a bleeding risk score, to help clinicians implement clinical guidelines on the use of aspirin in primary prevention.

Please note that research on aspirin in primary prevention among individuals younger than age 50 or 70 and older is limited.

A web-based version Aspirin-Guide is available at www.aspiringuide.com and is accessible from any computer or smartphone.

Hide.. Show more..

Screenshots

User Rating

0 out of 5

0 ratings in Dominican Republic

Ratings History

Reviews

App doesn't have any reviews yet

Store Rankings

Ranking History

App Ranking History not available yet

Category Rankings

App is not ranked yet

Keywords

Users may also like

Name	Reviews	Recent release
Contraception Point-of-Care Joshua Steinberg & RHAP	0	1 month ago
ASCVD Risk Estimator Plus	0	1 month ago
ADA Standards of Care	0	2 months ago
ABFM CKSA	0	1 year ago
ManageAnticoag	0	8 months ago
GOLD 2021 Pocket Guide	0	3 years ago
Preop Eval	0	1 year ago
The Medical Letter	0	3 years ago
Lipid Manager	0	3 months ago
Johns Hopkins Menopause Guide Improving Women’s Health	0	11 months ago